Herriot Tabuteau, Chief Executive Officer, 10% Owner at Axsome Therapeutics, Inc. (AXSM), sold 32,410 shares at $185.60 ($6.0M) on 2026-02-02, disclosed to the SEC on 2026-02-02.
Scheduled sale ($6.0M) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AXSM | SELL | 2026-06-09 | $12.0M | — | Filing → |
| AXSM | SELL | 2026-01-07 | $23.9M | — | Filing → |
| AXSM | SELL | 2025-12-04 | $23.3M | — | Filing → |